Deletion of tumor cell–derived IL-6 increased mouse survival, with median survival of 24 d in KPC IL6KO tumor mice compared with 17 d in KPC tumor mice (P = 0.001; Fig. 2 J). This evidence concerns the gene IL6 and neoplasm.